Arbutus Biopharma Corporation (Nasdaq: ABUS) recently presented compelling data on its investigational hepatitis B therapies, ...

Vir Biotechnology (NASDAQ:VIR) on Friday announced 24-week post-end-of-treatment data from a mid-stage trial for tobevibart ...

Experts highlight ten common requests received in their Gastroenterology advice and guidance service and explain how these ...

A pioneering study uncovers crucial immune dynamics in hepatitis B, offering new insights into how immune responses evolve ...

Hailing from Ocala, Florida, A Day To Remember has carved out a career by a unique fusing of pop-punk and metal-core. A Day To Remember’s Attack of the Killer B-Sides might wear the label of a stopgap ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg ... in childhood is associated with fewer basal core promoter gene mutations, and predicting a lower risk of HBeAg-negative ...

Its administration is based on a two-dose approach where each approach uses a different viral vector: a chimpanzee adenovirus (ChAdOx) prime followed by a modified vaccinia Ankara virus (MVA) boost – ...

Hepatocyte cell cycle may influence hepatitis B virus (HBV) replication and hepatitis B core antigen (HBcAg) expression, which is a major target for antiviral immune response. The aim of the ...

Another 2.4 million people in this country are chronically infected with hepatitis B, which is the leading cause of liver cancer globally. Hepatitis B is preventable, and hepatitis C is curable.